title: Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years.
abstract: Different causes of mortality have been described over different decades followed by description of pathogens identified from infective episodes that led to death. A retrospective review was performed in 3,831 hospitalized systemic lupus erythematosus (SLE) patients in Peking Union Medical College Hospital from January 1986 to April 2012. The primary causes of death were identified, and the constituent ratio of specific death causes during different periods was compared. Among 3,831 hospitalized SLE patients, 268 patients died, accounting for 7.0 %. No significant difference of death rate was found between men and women, P = 0.404. The three most frequent death causes according to decade were as follows: for 1986-1995, renal involvement, lupus encephalopathy, and infections; for 1996-2005, infections, lupus encephalopathy, and renal involvement; and for 2006-2012, infections, lupus encephalopathy, and pulmonary hypertension. Certain types of deaths, primarily related to lupus activity, have decreased over time, whereas infections, often attributed to the use of corticosteroid and immunosuppressant medications, have increased gradually and changed to the most frequent death causes of SLE. Early mortality (<3 years) occurred more commonly in lupus encephalopathy, while late death (>3 years) happened more frequently in renal involvement, pulmonary artery hypertension, cardiovascular events, and cancer. In SLE death cases mainly dying from infection, mixed infections were more frequent than single pathogen infection (60.5 vs. 39.5 %), including common bacteria, fungal infection, and cytomegalovirus. Aspergillus fumigatus and Pneumocystis carinii were the two most commonly infected pathogens, and Cytomegalovirus was a frequent pathogen of mixed infection. Aggressive therapy has effectively reduced the mortality related to disease activity but also was associated with life-threatening infections. Mixed and fungal infection should be considered when SLE patients have severe infection.
authors.affiliation: Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
authors.forename: Yunyun
authors.initials: Y
authors.lastname: Fei
authors.forename: Xiaochun
authors.initials: X
authors.lastname: Shi
authors.forename: Fengying
authors.initials: F
authors.lastname: Gan
authors.forename: Xuemei
authors.initials: X
authors.lastname: Li
authors.forename: Wen
authors.initials: W
authors.lastname: Zhang
authors.forename: Mengtao
authors.initials: M
authors.lastname: Li
authors.forename: Yong
authors.initials: Y
authors.lastname: Hou
authors.forename: Xuan
authors.initials: X
authors.lastname: Zhang
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhao
authors.forename: Xiaofeng
authors.initials: X
authors.lastname: Zeng
authors.forename: Fengchun
authors.initials: F
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects; D000328:Adult; D000368:Aged; D001232:Aspergillus fumigatus; D001927:Brain Diseases / Q000150:complications / Q000401:mortality; D002423:Cause of Death; D003587:Cytomegalovirus; D005260:Female; D006760:Hospitalization; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000401:mortality; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D007239:Infections / Q000150:complications / Q000401:mortality; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000382:microbiology* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D045363:Pneumocystis carinii; D051437:Renal Insufficiency / Q000150:complications / Q000401:mortality; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents
references.citation: Rheumatology (Oxford). 2007 Mar;46(3):539-44
references.pmid: 17043051
references.citation: J Rheumatol. 1995 Jul;22(7):1259-64
references.pmid: 7562755
references.citation: Arthritis Rheum. 2006 Aug;54(8):2550-7
references.pmid: 16868977
references.citation: Arch Intern Med. 2001 Jun 25;161(12):1557
references.pmid: 11427107
references.citation: Nephrol Dial Transplant. 2012 Aug;27(8):3248-54
references.pmid: 22523116
references.citation: Arthritis Rheum. 2011 May;63(5):1182-9
references.pmid: 21391198
references.citation: Am J Epidemiol. 2012 Oct 15;176(8):708-19
references.pmid: 23024137
references.citation: Am J Med. 2006 Aug;119(8):700-6
references.pmid: 16887417
references.citation: Arthritis Res Ther. 2012;14(2):R46
references.pmid: 22390680
references.citation: Ann Rheum Dis. 2003 Nov;62(11):1071-7
references.pmid: 14583570
references.citation: Lupus. 2011 Aug;20(9):965-71
references.pmid: 21659421
references.citation: Arthritis Rheum. 2003 Nov;48(11):3159-67
references.pmid: 14613278
references.citation: Lupus. 2013 Jan;22(1):106-11
references.pmid: 23112253
references.citation: Ann Rheum Dis. 2002 May;61(5):409-13
references.pmid: 11959764
references.citation: J Rheumatol. 2012 Mar;39(3):496-503
references.pmid: 22247362
references.citation: Lupus. 2009 Jun;18(7):661-6
references.pmid: 19433470
references.citation: Lupus. 2011 Aug;20(9):989-97
references.pmid: 21700655
references.citation: Lupus. 2010 Sep;19(10):1204-9
references.pmid: 20515999
references.citation: Rheumatology (Oxford). 2007 Sep;46(9):1487-91
references.pmid: 17681980